지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Recurrent Unilateral Vogt-Koyanagi- Harada Disease with Posterior Scleritis
Korean Journal of Ophthalmology
2015 .01
Comparison of the Clinical Manifestations between Acute Vogt- Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy
Korean Journal of Ophthalmology
2015 .01
Long-term safety and efficacy of adalimumab for intestinal Behçet’s disease in the open label study following a phase 3 clinical trial
Intestinal research
2017 .01
Surgical Outcomes of Nonadjustable Modified Harada-Ito Surgery
Korean Journal of Ophthalmology
2021 .12
Adalimumab Treatment in Pediatric-Onset Crohn’s Disease Patients after Infliximab Failure: A Single Center Study
Pediatric Gastroenterology, Hepatology & Nutrition
2016 .01
Pulmonary Sarcoidosis Induced by Adalimumab: A Case Report and Literature Review
Yonsei Medical Journal
2016 .01
국내 한의학 학술지에 게재된 망막과 시신경질환 관련 논문들의 경향성 분석
한방안이비인후피부과학회지
2023 .05
Adalimumab 치료 후 발생한 Myopathy 1예
대한건선학회지
2019 .01
Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
Gut and Liver
2022 .01
A Case of New-Onset Vitiligo in a Healthy Volunteer After Administration of Adalimumab
Annals of Dermatology
2021 .10
Could adalimumab be used safely and effectively in intestinal Behçet’s disease refractory to conventional therapy?
Intestinal research
2017 .01
Adalimumab or infliximab: which is better for perianal fistula in Crohn’s disease?
Intestinal research
2017 .01
체계적 문헌고찰 및 메타분석: 크론병 환자에서 Infliximab과 Adalimumab의 유효성 비교
보건의료기술평가
2021 .01
Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?
Annals of Dermatology
2015 .01
소아 염증성장질환 환자에서 adalimumab 치료 중 발생한 건선모양발진 1예
대한건선학회지
2019 .01
Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
Gut and Liver
2021 .01
Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
Gut and Liver
2016 .01
Risk Factor Associated with Recurrence after OM-89 (Uro-Vaxom®) Treatment for Female Recurrent Cystitis
Urogenital Tract Infection
2019 .01
Eruptive Benign Melanocytic Nevi Formation Following Adalimumab Therapy in a Patient with Crohn's Disease
Annals of Dermatology
2016 .01
Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn’s disease
Intestinal research
2017 .01
0